AIDS 2022 will take place in Montreal, Canada, and virtually from 29 July to 2 August 2022, with pre-conference meetings set to begin on 27 July 2022.

AIDS 2022 will be a hybrid conference, taking place in-person at the Palais des congrès de Montréal in Montreal, Canada, as well as virtually.

The conference chairs, organizing committee and Tourisme Montréal are working closely together to design a programme that is accessible and safeguards the well-being of all.

Registration and scholarships

Registration will open on Tuesday, 16 November 2021.

Yes. To ensure equitable access for people from low- and middle-income countries, the IAS will support in-person attendance and virtual participation through an ambitious scholarship programme. This will include the provision of internet data and devices to help bridge the digital divide for people in resource-limited settings.

Further information will be made available in the coming months.

Conference programme

Yes. Pre-conference meetings will take place on 27 and 28 July 2022. Further information will be made available in the coming months.

Abstract submissions will open on Tuesday, 16 November 2021.

Yes. There will be both in-person and virtual satellite symposia. Further information will be made available in the coming months.

Yes. There will be an exhibition. Further information will be made available in the coming months.

Yes. There will be a Global Village and Youth Programme. Submissions to the Global Village and Youth Programme will open on Tuesday, 16 November 2021.

Further information will be made available in the coming months.

Abstract submission

For AIDS 2022 – the 24th International AIDS Conference – an abstract is a standalone statement that briefly explains the essential information of a study, research project, policy or programme.

AIDS 2022 welcomes the submission of abstracts for original contributions to the field in the following scientific tracks:

  • Track A: Basic and translational science
  • Track B: Clinical science
  • Track C: Epidemiology and prevention science
  • Track D: Social and behavioural science
  • Track E: Implementation science, economics, systems and synergies with other health and development sectors
  • Track F: Political science, laws, ethics, policies and human rights.

Abstract submissions are open from 16 November 2021 to 27 January 2022, 23:59 Central European Time (CET). During this period, abstracts will be accepted through the online submission form available on the conference website.

Detailed descriptions of the scope and objectives of each scientific track, as defined by the AIDS 2022 Organizing Committee, can be found on the Abstract submission page.

The deadline for submission of abstracts is 27 January 2022, 23:59 CET.

Abstracts are intended to present scientific studies, research, programmes and policies, highlighting the methods and/or description and results and/or recommendations. If you are describing a study that is still in the planning stage, it would not be suitable for submission unless the method that you use is, for example, of particular scientific interest. However, if your study is ongoing and you have preliminary data that seems relevant or significant, please submit an abstract.

Late-breaker submissions must introduce data of unquestioned significance. Data analysed after the regular submission deadline (27 January 2022) should not be sent in as late breakers if the data do not meet an extremely high standard of scientific merit. The percentage of abstracts selected as late breakers will depend on the number of submissions made, but selection will certainly be more rigorous than for regular abstracts. A small number of late-breaker abstracts will be accepted for presentation orally or as posters at the conference.

During their abstract submission, authors will have to declare the reason why their abstract is a late breaker. The same submission rules apply for late-breaker abstracts as for regular abstracts, but each presenting author may present only one late-breaker abstract at the conference. Late-breaker abstract submission will be open from 20 April to 10 May 2022.

An abstract consists of a title, author list and abstract text no longer than 350 words. It can also include tables or graphs and/or images. Literature references should not be included.

AIDS 2022 offers two options for abstract submission:

Option 1

This is suitable for research conducted in all disciplines. Abstracts submitted under Option 1 should contain concise statements of:

  • Background: Indicate the purpose and objective of the research, the hypothesis that was tested or a description of the problem being analysed or evaluated.
  • Methods: Describe the study period, setting and location, study design, study population, data collection and methods of analysis used.
  • Results: Present as clearly and in as much detail as possible the findings and/or outcomes of the study. Please disaggregate data by age and gender where possible and summarize any specific results.
  • Conclusions: Explain the significance of the findings and/or outcomes of your study for HIV prevention, treatment, care and/or support and future implications of the results.

Option 2

This is suitable for lessons learned through programme, project or policy implementation or management. Abstracts submitted under Option 2 should contain concise statements of:

  • Background: Summarize the purpose, scope and objectives of the programme, project or policy.
  • Description: Describe the programme, project or policy period, setting and location, structure, key population (if applicable) and activities and interventions undertaken in support of the programme, project or policy.
  • Lessons learned: Present as clearly and in as much detail as possible the findings and/or outcomes of the programme, project or policy. Include an analysis or evaluation of lessons learned and best practices. Please summarize any specific results that support your lessons learned and best practices.
  • Conclusions/next steps: Explain the significance of the findings and/or outcomes of the programme, project or policy for HIV prevention, treatment, care and/or support and future implications of the results.

Before submitting an abstract, you are asked to create a conference account. One or several abstracts can be submitted through this account.

To submit abstracts, please log in to your conference account and click on the “Abstract submission” box on the conference account overview page. Then click on the red button, “Submit an abstract”. In the abstract submission system:

  1. Select the track, category and country of research. Enter your abstract title and text.
  2. Enter the presenting author and co-authors (individually).
  3. Preview your abstract and check format and correctness.
  4. Submit your abstract.

After an abstract has been created, modifications can be made at any time until the submission deadline. After submission, the abstract submitter will receive a confirmation email with an abstract reference number. Please refer to this reference number in all conference correspondence.

A tutorial on how to submit an abstract is available on the AIDS 2022 website.

After an abstract has been submitted via the conference account, modifications can be made until the submission deadline, 27 January 2022. After making your modifications, you need to resubmit your abstract. No modifications will be accepted after 27 January 2022.

A good abstract title is short, specific, representative and informative. It helps the reviewers categorize your abstract and, if accepted, it may help conference delegates find your presentation. The title should summarize your abstract without going into excessive details. Describe the topic clearly, including, for example, the population, country and issue of the research. Titles are limited to 30 words.

It is permitted but not mandatory to include tables or graphs and/or images in the abstract. A maximum of two tables, graphs or images in total can be included. A graph or image (in JPG, GIF or PNG, ideally 600dpi) counts as 50 words and a table counts as five words per row (50 words maximum). As a reminder, the abstract text body is limited to 350 words.

Please create your table or upload your graph or image following the instructions in the abstract submission system. Place the table, graph or image into your abstract text and save the changes. Review the abstract preview page to ensure that your table, graph and/or image displays properly.

There is no limit to the number of co-authors per abstract, although we strongly recommend the use of a study group name for abstracts with a high number of co-authors. A person can be listed as a co-author if they meet ALL the following criteria:

  1. They made substantial contributions to concept and design, acquisition of data or analysis and interpretation of data.
  2. They drafted the abstract or revised it for intellectual content.
  3. They approved the final version to be submitted.

If the abstract is accepted, the presenting authors are asked to disclose all financial and personal relationships between themselves and others that might be perceived as biasing their work. The conference organizer asks that all presenting authors disclose any conflict of interest at the time of presentation for the benefit of conference delegates. The purpose of this is to guarantee that all potential conflicts of interest are recognized and mechanisms to resolve them before the conference are implemented.

Material presented in abstracts should not violate any copyright laws. If figures, graphics and/or images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures, graphics and/or images for both worldwide print and web publication. The author must bear all reproduction costs charged by the copyright holder.

All submitted abstracts will go through a blind peer-review process by international reviewers. At least three reviewers will review each abstract. The AIDS 2022 Organizing Committee makes the final selection of abstracts to be included in the conference programme.

The highest-scoring abstracts will be selected for presentation in an oral abstract session. All e-posters will be displayed on site in the exhibition hall and virtually on the conference platform. In addition, a small number of high-scoring posters will be selected for oral presentation in e-poster sessions on site.

The methodology or study design presented in your abstract should be appropriate to address the purpose and objectives. Results or lessons learned should be clearly presented and support the conclusions. In addition, the findings should contribute to the advancement of knowledge and development in the field.

If English is not your native language, we strongly recommend that you arrange for a native English speaker working in your field to review your abstract before submission.

Please use the UNAIDS terminology guidelines when drafting and submitting your abstract. Please ensure that you DO NOT use stigmatizing language. DO use: people or person living with HIV; person or people with COVID-19; person or people with TB; healthcare seekers or clients. DO NOT label people as: HIV-infected; infected; cases; carriers; victims; patients.

You may check the common reasons for abstract rejection in the abstract submission guidelines.

You may also review examples of abstracts from previous conferences. If you need additional support, the Abstract Mentor Programme offers free, expert feedback to young or less experienced researchers interested in submitting an abstract for AIDS 2022. The programme is open from 8 November 2021 to 14 January 2022. Find out more by visiting the AMP webpage.

Notification of acceptance or rejection will be sent to the submitting (corresponding) author by mid-April.

To obtain a certificate for abstracts accepted, please contact [email protected].

The submission of the abstract constitutes the authors’ consent to publish. If the abstract is accepted, the authors agree that their abstract can be published under the Creative Commons Attribution 3.0 Unported (CC BY 3.0) licence. The licence allows third parties to share the published work (copy, distribute, transmit) and adapt it for any purposes, under the condition that AIDS 2022 and the authors are given credit, and that in the event of reuse or distribution, the terms of this licence are made clear. Authors retain the copyright of their abstracts, with first publication rights granted to IAS – the International AIDS Society.

An electronic abstract book will be available free of charge on the conference website.

Accepted abstracts will be published on IAS websites and in such publications as the AIDS 2022 online programme and other conference materials, the IAS abstract archive and the Journal of the International AIDS Society (JIAS).